“…Previous research on the family aggregation of AUDs, including studies that sought to identify clinical features associated with an increased familial risk, has been primarily limited by five factors: (a) the frequent use of nonrepresentative samples (i.e., clinic, referred, at-risk, twin, medical or forensic national registries) that, in turn, creates biases toward greater disorder severity or otherwise limits generalizability (Berkson, 1946; Low, Cui, & Merikangas, 2008; Munn-Chernoff et al, 2013; Røysamb & Tambs, 2016); (b) reliance on cross-sectional samples of probands rather than age-based cohorts followed longitudinally, which can be particularly problematic when evaluating clinical features related to etiology, onset, course, symptoms, and comorbidity given recall biases associated with retrospective reports (Haeny, Littlefield, & Sher, 2014; Moffitt et al, 2010); (c) the usual reliance on a single informant (often the proband) for ascertaining AUD diagnostic histories among first-degree relatives; (d) insufficient evaluations as to whether clinical features denoting family-based AUD risk are accounted for by other forms of family-based psychopathology and, consequently, nonspecific indicators of family-based AUD risk; and (e) questionable operational definitions of clinical features. As examples of this latter limitation, Milne (Milne et al, 2009) and Kendler (Kendler et al, 2016) defined “episode recurrence” as the diagnosis of AUD on two separate occasions without any demonstration of first-episode remission or recovery.…”